Dissemination (Meeting Coverage)

Among people with HIV (PWH), racial disparities in cancer outcomes have not been fully examined in...

People with HIV experience a high prevalence of mental health (MH) conditions and associated...

The following is a summary of “DOUBLING DOLUTEGRAVIR DOSAGE REDUCES HIV PERSISTENCE MARKERS...

The following is a summary of “D2EFT: DOLUTEGRAVIR AND DARUNAVIR EVALUATION IN ADULTS...

NIH-supported study demonstrates injectable ART may improve outcomes in underserved patients A...

The following is a summary of “(NEURO)INFLAMMATORY BIOMARKERS MEDIATE THE ASSOCIATION...

The following is a summary of “IMPACT OF HIV RESERVOIR IN THE LOSS OF NATURAL ELITE CONTROL...

The following is a summary of “ONE-YEAR MORTALITY OF PEOPLE WITH HIV AFTER INTENSIVE CARE...

The following is a summary of “PAGE-B SCORE TO ESTIMATE THE HEPATOCELLULAR CARCINOMA RISK IN...

In HCC with macroscopic vascular invasion, hepatic resection was significantly linked with better...

In patients with rectal cancer, neoadjuvant radiotherapy (RT) followed by atezolizumab and...

Adding bevacizumab to atezolizumab plus cisplatin and gemcitabine did not significantly improve...

The phase 3 SUNLIGHT trial demonstrated that bevacizumab plus trifluridine/tipiracil (FTD/TPI)...

The triplet regimen of nab-paclitaxel plus gemcitabine plus cisplatin (GCN) did not improve the...

The postoperative adjuvant combination therapy of sorafenib plus transarterial chemoembolization...

Patients with pre-treated, advanced biliary tract cancer (BTC) may benefit from treatment with...

The phase 3 NAPOLI-3 trial showed that liposomal irinotecan plus 5-fluorouracil/leucovorin and...

Zolbetuximab added to mFOLFOX6 improved the progression-free survival (PFS) and overall survival...

Single fraction radiation therapy (RT) outperformed best supportive care in reducing hepatic pain...

Therapy with atezolizumab (atezo) plus bevacizumab (bev) in systemic treatment (tx)-naive patients...